Search details
1.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37972660
2.
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
J Transl Med
; 22(1): 242, 2024 Mar 05.
Article
in English
| MEDLINE | ID: mdl-38443899
3.
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
Cancer Immunol Immunother
; 72(11): 3707-3716, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37638980
4.
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Oncologist
; 27(6): e484-e493, 2022 06 08.
Article
in English
| MEDLINE | ID: mdl-35429394
5.
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
Oncologist
; 24(11): 1424-1431, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31152079
6.
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).
Oncologist
; 24(6): e318-e326, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30846513
7.
Targeted α Therapies for the Treatment of Bone Metastases.
Int J Mol Sci
; 19(1)2017 Dec 28.
Article
in English
| MEDLINE | ID: mdl-29283383
8.
Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma.
Future Oncol
; 12(7): 909-19, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26883094
9.
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
BJU Int
; 115(5): 764-71, 2015 May.
Article
in English
| MEDLINE | ID: mdl-24988879
10.
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients.
Future Oncol
; 11(6): 965-73, 2015.
Article
in English
| MEDLINE | ID: mdl-25760977
11.
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.
Future Oncol
; 10(10): 1741-50, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24641206
12.
Bevacizumab-Based Therapy for Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Preliminary Results.
Chemotherapy
; 60(5-6): 294-9, 2014.
Article
in English
| MEDLINE | ID: mdl-25999127
13.
Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature.
Anticancer Drugs
; 24(1): 90-7, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23075631
14.
CA125 reference values change in male and postmenopausal female subjects.
Clin Chem Lab Med
; 51(2): 413-9, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23006901
15.
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies.
Eur J Cancer
; 195: 113399, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37950941
16.
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.
J Clin Oncol
; 41(34): 5263-5273, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37535876
17.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
EClinicalMedicine
; 61: 102044, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37434748
18.
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Front Oncol
; 13: 1152123, 2023.
Article
in English
| MEDLINE | ID: mdl-37260975
19.
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
iScience
; 26(11): 107970, 2023 Nov 17.
Article
in English
| MEDLINE | ID: mdl-37860695
20.
Cilengitide in bevacizumab-refractory high-grade glioma: two case reports and critical review of the literature.
Anticancer Drugs
; 23(7): 749-53, 2012 08.
Article
in English
| MEDLINE | ID: mdl-22382388